96 related articles for article (PubMed ID: 17112774)
1. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
[TBL] [Abstract][Full Text] [Related]
6. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
[TBL] [Abstract][Full Text] [Related]
7. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
[TBL] [Abstract][Full Text] [Related]
10. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
[TBL] [Abstract][Full Text] [Related]
11. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
[TBL] [Abstract][Full Text] [Related]
12. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
[TBL] [Abstract][Full Text] [Related]
13. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
14. Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.
Ali MA; Gunduz M; Gunduz E; Tamamura R; Beder LB; Katase N; Hatipoglu OF; Fukushima K; Yamanaka N; Shimizu K; Nagatsuka H
Cancer Invest; 2010 Jun; 28(5):495-500. PubMed ID: 20014947
[TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.
Na II; Kang HJ; Cho SY; Koh JS; Lee JK; Lee BC; Lee GH; Lee YS; Yoo HJ; Ryoo BY; Yang SH; Shim YS
Eur J Cancer; 2007 Feb; 43(3):520-6. PubMed ID: 17224267
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
[TBL] [Abstract][Full Text] [Related]
20. Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
Spindler KL; Nielsen JN; Lindebjerg J; Brandslund I; Jakobsen A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):500-4. PubMed ID: 16757132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]